Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+2.43M
-
Total reported value, excl. options
-
$409M
-
Value change
-
+$66M
-
Number of buys
-
44
-
Number of sells
-
-23
-
Price
-
$29.64
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2015
77 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2015.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 170M outstanding shares and own 8.11% of the company stock.
Largest 10 shareholders include FMR LLC (5.84M shares), PRICE T ROWE ASSOCIATES INC /MD/ (959K shares), Flagship Ventures 2007 General Partner LLC (599K shares), FEDERATED INVESTORS INC /PA/ (572K shares), WADDELL & REED FINANCIAL INC (484K shares), VANGUARD GROUP INC (480K shares), TimesSquare Capital Management, LLC (445K shares), JENNISON ASSOCIATES LLC (392K shares), BlackRock Advisors LLC (338K shares), and Capital World Investors (288K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.